Skip to main content
Clinical Trials/NCT04961125
NCT04961125RecruitingNot Applicable

Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in China

Second Affiliated Hospital, School of Medicine, Zhejiang University5 sites in 1 country200 target enrollmentStarted: August 2, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
200
Locations
5
Primary Endpoint
germline variant detection rate in the polyposis population

Study Overview

Brief Summary

Patients suspected of adenomatous polyposis were included. The criteria used were more than 10 polyps observed under colonoscopy, and pathological confirmation of adenoma. Clinical data and pedigree information were collected. The variants of 139 genes associated with different hereditary cancers and polyposis were screened by NGS, which was performed by Genetron Health on the HiSeqX-ten sequencing platform.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • clinical diagnosis of adenomatous polyposis;
  • enough samples (provide at least 5ml of peripheral whole blood) for germline variant detection

Exclusion Criteria

  • genetic diagnosis of polyposis syndrome

Outcomes

Primary Outcomes

germline variant detection rate in the polyposis population

Time Frame: through study completion, an average of 3 years

germline variant detection rate in the polyposis population

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials